83 related articles for article (PubMed ID: 2318551)
1. Vinpocetine therapy does not change imipramine pharmacokinetics in man.
Hitzenberger G; Schmid R; Braun W; Grandt R
Int J Clin Pharmacol Ther Toxicol; 1990 Mar; 28(3):99-104. PubMed ID: 2318551
[TBL] [Abstract][Full Text] [Related]
2. Vinpocetine pharmacokinetics in elderly subjects.
Grandt R; Beitinger H; Schaltenbrand R; Braun W
Arzneimittelforschung; 1989 Dec; 39(12):1599-602. PubMed ID: 2624613
[TBL] [Abstract][Full Text] [Related]
3. Influence of vinpocetine on warfarin-induced inhibition of coagulation.
Hitzenberger G; Sommer W; Grandt R
Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):323-8. PubMed ID: 2272713
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the possible influence of the absorption of vinpocetine with concomitant application of magnesium-aluminium-hydroxide gel.
Lohmann A; Grobara P; Dingler E
Arzneimittelforschung; 1991 Nov; 41(11):1164-7. PubMed ID: 1810262
[TBL] [Abstract][Full Text] [Related]
5. Glibenclamide steady state plasma levels during concomitant vinpocetine administration in type II diabetic patients.
Grandt R; Braun W; Schulz HU; Lührmann B; Frercks HJ
Arzneimittelforschung; 1989 Nov; 39(11):1451-4. PubMed ID: 2515864
[TBL] [Abstract][Full Text] [Related]
6. The influence of the route of administration of imipramine on imipramine and desipramine blood levels.
Rigal J; Albin H; Fança X; Demotes-Mainard F; Vinçon G
J Clin Psychopharmacol; 1989 Oct; 9(5):364-7. PubMed ID: 2677063
[TBL] [Abstract][Full Text] [Related]
7. Fluvoxamine-induced alterations in plasma concentrations of imipramine and desipramine in depressed patients.
Spina E; Pollicino AM; Avenoso A; Campo GM; Caputi AP
Int J Clin Pharmacol Res; 1993; 13(3):167-71. PubMed ID: 8225700
[TBL] [Abstract][Full Text] [Related]
8. Imipramine-cimetidine interaction: impairment of clearance and enhanced absolute bioavailability.
Abernethy DR; Greenblatt DJ; Shader RI
J Pharmacol Exp Ther; 1984 Jun; 229(3):702-5. PubMed ID: 6726654
[TBL] [Abstract][Full Text] [Related]
9. The relationship of plasma imipramine and N-desmethylimipramine to improvement in agoraphobia.
Mavissakalian M; Perel JM; Michelson L
J Clin Psychopharmacol; 1984 Feb; 4(1):36-40. PubMed ID: 6693582
[TBL] [Abstract][Full Text] [Related]
10. Patterns of plasma imipramine-desipramine concentrations in patients receiving concomitant fluphenazine decanoate.
Siris SG; Adan F; Lee A; Cooper TB; Mandeli J; Casey E
J Clin Psychiatry; 1988 Feb; 49(2):64-5. PubMed ID: 3338977
[TBL] [Abstract][Full Text] [Related]
11. The relationship of plasma imipramine and N-desmethylimipramine to response in panic disorder.
Mavissakalian MR; Perel JM
Psychopharmacol Bull; 1996; 32(1):143-7. PubMed ID: 8927664
[TBL] [Abstract][Full Text] [Related]
12. Relative bioavailability of imipramine (Tofranil) coated tablets in healthy volunteers.
Ullmann U; Lehnfeld R; Bliesath H; Birkel M; Gebbing H; Gräve M; Wolf H
Int J Clin Pharmacol Ther; 2001 Jun; 39(6):271-6. PubMed ID: 11430636
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetics and disposition of vinpocetine in rats].
Yao JH; Su CY; Chu XY
Yao Xue Xue Bao; 1994; 29(2):81-5. PubMed ID: 8042515
[TBL] [Abstract][Full Text] [Related]
14. Effect of fluvoxamine on the pharmacokinetics of imipramine and desipramine in healthy subjects.
Spina E; Pollicino AM; Avenoso A; Campo GM; Perucca E; Caputi AP
Ther Drug Monit; 1993 Jun; 15(3):243-6. PubMed ID: 8333005
[TBL] [Abstract][Full Text] [Related]
15. Depression in children: relationship between plasma imipramine levels and response.
Preskorn SH; Weller EB; Weller RA
J Clin Psychiatry; 1982 Nov; 43(11):450-3. PubMed ID: 7174621
[TBL] [Abstract][Full Text] [Related]
16. Optimized preparation of vinpocetine proliposomes by a novel method and in vivo evaluation of its pharmacokinetics in New Zealand rabbits.
Xu H; He L; Nie S; Guan J; Zhang X; Yang X; Pan W
J Control Release; 2009 Nov; 140(1):61-8. PubMed ID: 19651165
[TBL] [Abstract][Full Text] [Related]
17. Cerebral circulatory and cardiac effects of vinpocetine and its metabolite, apovincaminic acid, in anesthetized dogs.
Imamoto T; Tanabe M; Shimamoto N; Kawazoe K; Hirata M
Arzneimittelforschung; 1984; 34(2):161-9. PubMed ID: 6539108
[TBL] [Abstract][Full Text] [Related]
18. Vinpocetine blockade of sodium channels inhibits the rise in sodium and calcium induced by 4-aminopyridine in synaptosomes.
Sitges M; Galván E; Nekrassov V
Neurochem Int; 2005 Jun; 46(7):533-40. PubMed ID: 15843047
[TBL] [Abstract][Full Text] [Related]
19. Single and combined effects of carbamazepine and vinpocetine on depolarization-induced changes in Na+, Ca2+ and glutamate release in hippocampal isolated nerve endings.
Sitges M; Chiu LM; Nekrassov V
Neurochem Int; 2006 Jul; 49(1):55-61. PubMed ID: 16621162
[TBL] [Abstract][Full Text] [Related]
20. [Mechanism of action of vinpocetine].
Kiss B; Kárpáti E
Acta Pharm Hung; 1996 Sep; 66(5):213-24. PubMed ID: 9082841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
